Your browser doesn't support javascript.
loading
Spirometry parameters used to define small airways obstruction in population-based studies: systematic review protocol.
Knox-Brown, Ben; Mulhern, Octavia; Amaral, Andre F S.
Affiliation
  • Knox-Brown B; National Heart and Lung Institute, Imperial College London, London, UK.
  • Mulhern O; National Heart and Lung Institute, Imperial College London, London, UK.
  • Amaral AFS; National Heart and Lung Institute, Imperial College London, London, UK a.amaral@imperial.ac.uk.
BMJ Open ; 11(10): e052931, 2021 10 05.
Article in En | MEDLINE | ID: mdl-34610942
ABSTRACT

INTRODUCTION:

In recent years, there has been increasing interest in the use of spirometry for the assessment of small airways obstruction (SAO) driven by the idea that these changes occur prior to development of established obstructive lung disease. Maximal mid-expiratory and distal flow rates have been widely used despite a lack of agreement regarding parameter selection or definition of an abnormal result. We aim to provide evidence from population-based studies, describing the different parameters, definitions of normal range and the resulting impact on prevalence estimates for SAO. Summarising this evidence is important to inform development of future studies in this area. METHODS AND

ANALYSIS:

A systematic review of population-based studies will be conducted. MEDLINE, Web of Science and Google Scholar will be searched from database inception to May 2021. Primary outcomes will include the spirometry parameter used to define SAO, and the definition of an abnormal result. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines will be followed for study selection. Study methods will be assessed using the Newcastle-Ottawa scale and the Grading of Recommendations Assessment, Development and Evaluation working group methodology. Narrative synthesis will be conducted for all included studies. Meta-analysis will also be conducted for prevalence estimates and associated risk factors where data quality and availability allow. Random effects models will be used to conduct the meta-analysis and I2 statistics will be used to assess heterogeneity across studies. Where appropriate subgroup analysis will be conducted to explore heterogeneity. ETHICS AND DISSEMINATION There is no requirement for ethical approval for this project. Findings will be disseminated via peer-reviewed publications and other formats, for example, conferences, congresses or symposia. PROSPERO REGISTRATION NUMBER CRD42021250206.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design Type of study: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspects: Ethics Limits: Humans Language: En Journal: BMJ Open Year: 2021 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design Type of study: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspects: Ethics Limits: Humans Language: En Journal: BMJ Open Year: 2021 Document type: Article Affiliation country: United kingdom